5KW Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - SkinBioTherapeutics PLC

Watchlist Manager

Watchlist

Price: 0.092 EUR Market Closed

Market Cap: €19.4m

	SkinBioTherapeutics PLC F:5KW	UK
	CellaVision AB OTC:CLVSF	SE
	Barloworld Ltd OTC:BRRAY	ZA
	Fuji Seal International Inc OTC:FUJSF	JP

Profitability Summary

SkinBioTherapeutics PLC's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

61%

Strong 3Y Average Gross Margin

60%

Declining Gross Margin

64% > 61%

Negative Operating Margin

-21%

Negative 3Y Average Operating Margin

-452%

Operating Margin is Increasing

-2 271% > -21%

Negative Net Margin

-9%

Negative 3Y Average Net Margin

-429%

Net Margin is Increasing

-2 146% > -9%

Negative Free Cash Flow Margin

-40%

Negative 3Y Average Free Cash Flow Margin

-480%

Free Cash Flow Margin is Increasing

-2 127% > -40%

Negative ROE

-7%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-127%

ROIC is Increasing

-357% > -19%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.